PKANF yields 967.12% · PFE yields 6.13%● Live data
📍 PKANF pulled ahead of the other in Year 1
Combined, PKANF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PKANF + PFE for your $10,000?
Simply Better Brands Corp. manufactures and sells hemp-based cannabidiol related products in the United States. The company offers tinctures, topicals, capsules, gummies, pet tinctures and treats, bath bombs, pet wellness products, and skincare products comprising caffeine eye cream, retinol night cream, charcoal peel-off masks, moisturizers, serums, toner, cleanser, and acne patches. It also provides nutritious bars. The company offers its products under the PureKana, Tru Brand, BudaPets, and No BS brands. Simply Better Brands Corp. sells its products through its own e-commerce platforms, and brick and mortar retailers. The company was formerly known as PureK Holdings Corp. and changed its name to Simply Better Brands Corp. in May 2021. The company was founded in 2017 and is headquartered in Vancouver, Canada. Simply Better Brands Corp. is a subsidiary of Heavenly Rx Ltd.
Full PKANF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.